Enzyme News and Research

RSS

Paracetamol use in infancy may increase risk of developing asthma by the age of 18

Children who take paracetamol during their first two years of life may be at a higher risk of developing asthma by the age of 18, especially if they have a particular genetic makeup, according to new research presented at the European Respiratory Society International Congress today.

17 Sep 2018

Caspase-2 enzyme inhibitor could provide effective way to stop aggressive fatty liver disease

Researchers at University of California San Diego School of Medicine have discovered using mice and human clinical specimens, that caspase-2, a protein-cleaving enzyme, is a critical driver of non-alcoholic steatohepatitis, a chronic and aggressive liver condition.

14 Sep 2018

New statement provides detailed overview of how to diagnose, treat resistant hypertension

Resistant hypertension affects 12 percent to15 percent of patients treated for high blood pressure according to a new scientific statement from the American Heart Association.

14 Sep 2018

Researchers identify mechanism that could make pathogens more susceptible to antibiotics

Scientists at the Research Institute of the McGill University Health Centre (RI-MUHC) have identified new means of fighting drug-tolerant bacteria, a growing global threat as menacing as drug-resistant microbes.

14 Sep 2018

Protein involved in milk production appears to stimulate growth and spread of breast cancer

VCU Massey Cancer Center researchers have identified a protein involved in milk production that stimulates the growth and spread of breast cancer and could ultimately serve as a target for novel therapies to treat breast cancer.

12 Sep 2018

Study opens up new possibilities for designing novel medicines

A study by the Computational Biochemistry Research Group of the Universitat Jaume I of Castellón, Spain, shows that enzyme activity depends on electrostatic properties, as opposed to mechanical ones.

11 Sep 2018

Gene involved in circadian rhythms can be potential target for glioblastoma treatment

Scientists with the Virginia Tech Carilion Research Institute say a gene involved in the body's circadian rhythms is a potential target for therapies to help patients with a deadly form of brain cancer known as glioblastoma.

11 Sep 2018

BAP1 protein serves as tumor suppressor gene in kidney, eye, bile duct and mesothelioma cancers

Researchers at The University of Texas MD Anderson Cancer Center have shown how BRCA-associated protein 1 (BAP1) serves as a tumor suppressor gene in kidney, eye, bile duct, mesothelioma and other cancers by regulating a form of cell death called ferroptosis, opening up a potential new area of therapy research.

10 Sep 2018

Researchers uncover secret of immortality mechanism in aggressive glioblastoma

UC San Francisco researchers have discovered how a mutation in a gene regulator called the TERT promoter -- the third most common mutation among all human cancers and the most common mutation in the deadly brain cancer glioblastoma -- confers "immortality" on tumor cells, enabling the unchecked cell division that powers their aggressive growth.

10 Sep 2018

RUDN biochemists describe previously unknown mechanism of autoimmunity regulation

The ability of a human body to resist pathogenic factors is under control of immune cells, the most important of which are lymphocytes.

7 Sep 2018

Major pitfall identified in popular prostate cancer PET imaging method

Prostate-specific membrane antigen positron emission tomography imaging has become a popular method for determining the stage of a patient's prostate cancer.

7 Sep 2018

Chemical signals influence guest-host protocell interactions

Resident artificial cells shown to leave their protocell hosts when triggered by a chemical signal that causes them to behave antagonistically.

7 Sep 2018

Researchers describe novel mechanism that links epigenetic change to translational control

Understanding how memories form and are retrieved has applications to psychiatric, neurological and neurodegenerative disorders, and may be helpful to attenuate maladaptive memories in psychiatric disorders.

7 Sep 2018

New study aims to understand why skin grafts have high rate of rejection

When it comes to transplant rejection, some organs are far trickier than others. Some transplantable organs, such as the liver, are readily accepted by the recipient's immune system, rarely triggering an immune response and rejection

7 Sep 2018

New system accelerates discovery of chemical compounds that inhibit enzyme implicated in cancers

Researchers at the National Center for Advancing Translational Sciences, part of the National Institutes of Health, have developed a system to accelerate the discovery of chemical compounds that inhibit an enzyme implicated in a number of cancers.

6 Sep 2018

UA researchers receive $4.4 million grant to focus on idiopathic pulmonary fibrosis

Scar tissue is a good thing. When you fall and scrape your knee, the natural process jumps into gear, sealing up wounds and healing damaged tissue.

6 Sep 2018

Breakthrough fluorine discovery may impact how pharmaceutical companies develop new drugs

A groundbreaking discovery by chemists at The University of Texas at San Antonio will have a significant impact on how pharmaceutical companies develop new drug treatments.

6 Sep 2018

New nuclear medicine imaging method could help diagnose widespread tumors

A new nuclear medicine imaging method could help diagnose widespread tumors, such as breast, colon, pancreas, lung and head and neck cancer better than current methods, with less inconvenience to patients and with equal or improved accuracy.

6 Sep 2018

Researchers make discovery about yeast metabolism that could help drug developers

Researchers at the Francis Crick Institute have developed machine learning algorithms that can predict the metabolism of yeast based on its protein content.

6 Sep 2018

Researchers identify enzyme that plays vital role in sexual development of fungi

Biologists at Ruhr-Universität Bochum and Georg-August-Universität Göttingen have gained new insights into specific enzymes that effect the specialization of fungal cells.

5 Sep 2018

Enzyme News and Research

Paracetamol use in infancy may increase risk of developing asthma by the age of 18

Caspase-2 enzyme inhibitor could provide effective way to stop aggressive fatty liver disease

New statement provides detailed overview of how to diagnose, treat resistant hypertension

Researchers identify mechanism that could make pathogens more susceptible to antibiotics

Protein involved in milk production appears to stimulate growth and spread of breast cancer

Study opens up new possibilities for designing novel medicines

Gene involved in circadian rhythms can be potential target for glioblastoma treatment

BAP1 protein serves as tumor suppressor gene in kidney, eye, bile duct and mesothelioma cancers

Researchers uncover secret of immortality mechanism in aggressive glioblastoma

RUDN biochemists describe previously unknown mechanism of autoimmunity regulation

Major pitfall identified in popular prostate cancer PET imaging method

Chemical signals influence guest-host protocell interactions

Researchers describe novel mechanism that links epigenetic change to translational control

New study aims to understand why skin grafts have high rate of rejection

New system accelerates discovery of chemical compounds that inhibit enzyme implicated in cancers

UA researchers receive $4.4 million grant to focus on idiopathic pulmonary fibrosis

Breakthrough fluorine discovery may impact how pharmaceutical companies develop new drugs

New nuclear medicine imaging method could help diagnose widespread tumors

Researchers make discovery about yeast metabolism that could help drug developers

Researchers identify enzyme that plays vital role in sexual development of fungi

Understanding the DNA Damage Response in Innate Immunity eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo